The first 100 days of the second Trump presidency were marked by new, wide-ranging tariffs and executive orders along with workforce cuts and leadership changes. What are the immediate and long-term impacts of these shifts? And how has the healthcare industry responded?
Featuring: Alivia Kaylor, senior editor for Pharma Life Sciences at Xtelligent
Jacqueline LaPointe, executive editor of Editorial at Xtelligent
In today’s episode, we’ll cover…
Tariffs and their impact on drug supply chain
The impact of deregul...
The first 100 days of the second Trump presidency were marked by new, wide-ranging tariffs and executive orders along with workforce cuts and leadership changes. What are the immediate and long-term impacts of these shifts? And how has the healthcare industry responded?
Featuring: Alivia Kaylor, senior editor for Pharma Life Sciences at Xtelligent
Jacqueline LaPointe, executive editor of Editorial at Xtelligent
In today’s episode, we’ll cover…
- Tariffs and their impact on drug supply chain
- The impact of deregulation and workforce cuts on wasteful healthcare spending
- Understanding the role of executive orders in healthcare policy
and more!
To learn more about these topics, check out techtarget.com/healthcarepayers and techtarget.com/pharmalifesciences.
To watch clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.
References:
- Trump to expand, enforce healthcare price transparency
- How Trump's pharma tariffs disrupt drug supply chains
- Trump administration policies could create headwinds across healthcare: Fitch
View more